Current treatment algorithms for pulmonary arterial hypertension emphasize combination and parenteral therapies for greater efficacy, with lung transplantation remaining an option for inadequate responders.
No takes yet. Share an insight, caveat, or question.
Combination and parenteral regimens may support updated PAH algorithms; leaves open optimal sequencing and durability in prospective trials.
Chin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: